Variant report
Variant | rs2707975 |
---|---|
Chromosome Location | chr3:142611657-142611658 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | GATA3 | chr3:142611638-142612287 | SK-N-SH | brain: | n/a | n/a |
2 | USF1 | chr3:142611654-142611874 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | PBX3 | chr3:142611627-142612074 | SK-N-SH | brain: | n/a | n/a |
4 | USF1 | chr3:142611608-142611853 | SK-N-SH_RA | brain: | n/a | n/a |
5 | GATA3 | chr3:142611563-142612252 | SK-N-SH | brain: | n/a | n/a |
6 | USF1 | chr3:142611597-142611891 | HCT-116 | colon: | n/a | n/a |
7 | USF1 | chr3:142611528-142611947 | K562 | blood: | n/a | n/a |
8 | NFYB | chr3:142611546-142611907 | K562 | blood: | n/a | n/a |
9 | NFYB | chr3:142611554-142611832 | Hela-S3 | cervix: | n/a | n/a |
10 | USF1 | chr3:142611585-142611832 | A549 | lung: | n/a | n/a |
11 | USF1 | chr3:142611546-142611967 | SK-N-SH | brain: | n/a | n/a |
12 | USF1 | chr3:142611597-142611916 | SK-N-SH_RA | brain: | n/a | n/a |
13 | USF2 | chr3:142611638-142611921 | Hela-S3 | cervix: | n/a | chr3:142611753-142611764 |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:142611367..142612951-chr3:142614638..142616165,2 | MCF-7 | breast: | |
2 | chr3:142296468..142299283-chr3:142609997..142611852,2 | MCF-7 | breast: | |
3 | chr3:142609483..142612071-chr3:142616369..142619084,2 | K562 | blood: | |
4 | chr3:142606798..142610492-chr3:142610655..142614860,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PCOLCE2 | TF binding region |
ENSG00000175054 | Chromatin interaction |
ENSG00000163710 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1036691 | 0.88[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs1457684 | 1.00[CEU][hapmap];0.87[CHB][hapmap];0.94[JPT][hapmap];0.85[AMR][1000 genomes];0.99[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1457685 | 0.81[EUR][1000 genomes] |
rs1463559 | 0.87[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2125125 | 0.81[CEU][hapmap];0.90[GIH][hapmap];0.83[JPT][hapmap];0.96[TSI][hapmap];0.87[EUR][1000 genomes] |
rs2581619 | 1.00[CEU][hapmap];0.87[CHB][hapmap];1.00[GIH][hapmap];0.88[JPT][hapmap];0.94[MEX][hapmap];0.96[TSI][hapmap];0.87[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2581620 | 1.00[CEU][hapmap];0.87[CHB][hapmap];0.88[JPT][hapmap];0.86[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2581626 | 0.82[EUR][1000 genomes] |
rs2581629 | 0.88[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2581635 | 0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs2581636 | 1.00[CEU][hapmap];0.84[CHB][hapmap];0.83[JPT][hapmap];0.96[EUR][1000 genomes] |
rs2581637 | 1.00[CEU][hapmap];0.87[CHB][hapmap];0.95[GIH][hapmap];0.94[JPT][hapmap];0.83[MEX][hapmap];1.00[TSI][hapmap];0.82[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2608070 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.86[CHB][hapmap];0.98[GIH][hapmap];0.94[JPT][hapmap];0.82[LWK][hapmap];0.89[MEX][hapmap];0.90[MKK][hapmap];1.00[TSI][hapmap];0.91[AFR][1000 genomes];0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2608075 | 0.80[JPT][hapmap];0.81[EUR][1000 genomes] |
rs2608078 | 0.95[AFR][1000 genomes];0.92[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2608079 | 0.87[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2619147 | 0.82[CEU][hapmap];0.81[CHB][hapmap];0.83[MEX][hapmap];0.81[EUR][1000 genomes] |
rs2707973 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.94[MEX][hapmap];1.00[TSI][hapmap];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2707977 | 0.82[CEU][hapmap];0.81[EUR][1000 genomes] |
rs2707983 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.87[CHB][hapmap];0.95[GIH][hapmap];0.94[JPT][hapmap];0.84[MEX][hapmap];1.00[TSI][hapmap];0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2707985 | 0.87[CEU][hapmap];0.83[GIH][hapmap];0.96[TSI][hapmap];0.87[EUR][1000 genomes] |
rs2707991 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2707996 | 0.88[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2707997 | 0.82[EUR][1000 genomes] |
rs4683435 | 0.88[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs6778732 | 0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs7648216 | 0.82[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs893885 | 0.82[EUR][1000 genomes] |
rs9824548 | 0.82[CEU][hapmap];0.81[CHB][hapmap];0.81[EUR][1000 genomes] |
rs984593 | 0.82[CEU][hapmap];0.81[CHB][hapmap];0.81[EUR][1000 genomes] |
rs984594 | 0.82[CEU][hapmap];0.81[CHB][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv877562 | chr3:142573789-142846370 | Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
2 | nsv437342 | chr3:142605233-142622834 | Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
3 | nsv437343 | chr3:142607487-142622834 | Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
4 | esv3506087 | chr3:142609212-142614010 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
5 | esv3506084 | chr3:142609712-142613910 | Flanking Active TSS Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
6 | esv3506088 | chr3:142610248-142612881 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
7 | esv3463561 | chr3:142610248-142612883 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
8 | esv3506086 | chr3:142610271-142612846 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
9 | esv3506083 | chr3:142610303-142612813 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
10 | esv3506082 | chr3:142610364-142612765 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
11 | esv3463562 | chr3:142610368-142612763 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
12 | esv3506089 | chr3:142610368-142612763 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
13 | esv12862 | chr3:142610479-142612181 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
14 | nsv437886 | chr3:142610610-142611657 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
15 | nsv520851 | chr3:142610610-142611657 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
16 | nsv10332 | chr3:142610676-142613653 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:142608400-142615200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr3:142608600-142615200 | Weak transcription | Hela-S3 | cervix |
3 | chr3:142608600-142615400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr3:142608600-142617800 | Weak transcription | Aorta | Aorta |
5 | chr3:142609600-142613400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr3:142609600-142616800 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr3:142610000-142615200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr3:142610600-142611800 | Enhancers | K562 | blood |